ATE459361T1 - Therapeutische azidverbindungen - Google Patents
Therapeutische azidverbindungenInfo
- Publication number
- ATE459361T1 ATE459361T1 AT96932197T AT96932197T ATE459361T1 AT E459361 T1 ATE459361 T1 AT E459361T1 AT 96932197 T AT96932197 T AT 96932197T AT 96932197 T AT96932197 T AT 96932197T AT E459361 T1 ATE459361 T1 AT E459361T1
- Authority
- AT
- Austria
- Prior art keywords
- drugs
- azide
- therapeutic
- amine
- azide derivatives
- Prior art date
Links
- -1 AZIDE COMPOUNDS Chemical class 0.000 title abstract 6
- 230000001225 therapeutic effect Effects 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 abstract 7
- 239000003814 drug Substances 0.000 abstract 7
- 150000001540 azides Chemical class 0.000 abstract 5
- 150000001412 amines Chemical class 0.000 abstract 3
- 229940002612 prodrug Drugs 0.000 abstract 3
- 239000000651 prodrug Substances 0.000 abstract 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 2
- 238000001727 in vivo Methods 0.000 abstract 2
- 150000002576 ketones Chemical class 0.000 abstract 2
- 239000002777 nucleoside Chemical class 0.000 abstract 2
- 150000003833 nucleoside derivatives Chemical class 0.000 abstract 2
- SLWSQPYUSBXANQ-JFWOZONXSA-N 9-[(2r,3s,5s)-3-fluoro-5-(hydroxymethyl)oxolan-2-yl]-3h-purin-6-one Chemical compound O1[C@H](CO)C[C@H](F)[C@@H]1N1C2=NC=NC(O)=C2N=C1 SLWSQPYUSBXANQ-JFWOZONXSA-N 0.000 abstract 1
- JNTOCHDNEULJHD-UHFFFAOYSA-N Penciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(CCC(CO)CO)C=N2 JNTOCHDNEULJHD-UHFFFAOYSA-N 0.000 abstract 1
- 229960004150 aciclovir Drugs 0.000 abstract 1
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 230000008499 blood brain barrier function Effects 0.000 abstract 1
- 210000001218 blood-brain barrier Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229960001179 penciclovir Drugs 0.000 abstract 1
- 150000003212 purines Chemical class 0.000 abstract 1
- 150000003230 pyrimidines Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US338395P | 1995-09-07 | 1995-09-07 | |
| PCT/US1996/014494 WO1997009052A1 (en) | 1995-09-07 | 1996-09-06 | Therapeutic azide compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE459361T1 true ATE459361T1 (de) | 2010-03-15 |
Family
ID=21705613
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96932197T ATE459361T1 (de) | 1995-09-07 | 1996-09-06 | Therapeutische azidverbindungen |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US6271212B1 (de) |
| EP (1) | EP0852499B1 (de) |
| JP (1) | JPH11512397A (de) |
| AT (1) | ATE459361T1 (de) |
| AU (1) | AU709345B2 (de) |
| BR (1) | BR9610120A (de) |
| CA (1) | CA2231442A1 (de) |
| DE (1) | DE69638137D1 (de) |
| WO (1) | WO1997009052A1 (de) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU709345B2 (en) * | 1995-09-07 | 1999-08-26 | Emory University | Therapeutic azide compounds |
| JP2002528510A (ja) * | 1998-11-05 | 2002-09-03 | サントル・ナシオナル・ドウ・ラ・ルシエルシユ・シアンテイフイク | ＨＩＶ感染の治療のためのβ−Ｌ−２’−デオキシ−ヌクレオシド |
| WO2000026225A2 (en) | 1998-11-05 | 2000-05-11 | Centre National De La Recherche Scientifique | Nucleosides with anti-hepatitis b virus activity |
| US6407077B1 (en) | 1998-11-05 | 2002-06-18 | Emory University | β-L nucleosides for the treatment of HIV infection |
| EP1964569A3 (de) | 2000-04-13 | 2009-07-22 | Pharmasset, Inc. | 3'- oder 2'-Hydroxymethyl-substituierte Nukleosidderivate zur Behandlung von Virusinfektionen |
| MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
| EP1736478B1 (de) * | 2000-05-26 | 2015-07-22 | IDENIX Pharmaceuticals, Inc. | Verfahren und Zusammensetzungen zur Behandlung von Flaviviren und Pestiviren |
| US7608600B2 (en) | 2002-06-28 | 2009-10-27 | Idenix Pharmaceuticals, Inc. | Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections |
| CN1678326A (zh) * | 2002-06-28 | 2005-10-05 | 埃迪尼克斯(开曼)有限公司 | 用于治疗黄病毒感染的2'－c－甲基－3'－o－l－缬氨酸酯核糖呋喃基胞苷 |
| NZ537662A (en) | 2002-06-28 | 2007-10-26 | Idenix Cayman Ltd | 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
| LT1576138T (lt) | 2002-11-15 | 2017-06-26 | Idenix Pharmaceuticals Llc | 2`-šakoti nukleozidai derinyje su interferonu ir flaviviridae mutacija |
| WO2004050678A2 (en) * | 2002-12-03 | 2004-06-17 | Baylor University | Compounds resistant to metabolic deactivation and methods of use |
| AU2003300901A1 (en) | 2002-12-12 | 2004-06-30 | Idenix (Cayman) Limited | Process for the production of 2'-branched nucleosides |
| WO2004084453A2 (en) * | 2003-03-20 | 2004-09-30 | Microbiologica Quimica E Farmaceutica Ltd. | METHODS OF MANUFACTURE OF 2'-DEOXY-β-L-NUCLEOSIDES |
| NZ550102A (en) * | 2004-02-24 | 2010-10-29 | Univ California | Methods and materials for assessing prostate cancer therapies and compounds (thiohydantoine derivatives) |
| EP1809339A2 (de) * | 2004-10-07 | 2007-07-25 | Koninklijke Philips Electronics N.V. | Verbindungen, kits und verfahren zur verwendung in der medizinischen bilddarstellung |
| JP4516863B2 (ja) * | 2005-03-11 | 2010-08-04 | 株式会社ケンウッド | 音声合成装置、音声合成方法及びプログラム |
| MX2007012157A (es) * | 2005-04-01 | 2008-03-14 | Intezyne Technologies Llc | Micelas polimericas para suministro de farmacos. |
| US7709517B2 (en) | 2005-05-13 | 2010-05-04 | The Regents Of The University Of California | Diarylhydantoin compounds |
| EP1986700A2 (de) * | 2005-10-04 | 2008-11-05 | Koninklijke Philips Electronics N.V. | Staudinger-reaktion in der bildgebung und therapie sowie kits zur verwendung für bildgebung und therapie |
| ES2422290T3 (es) | 2005-12-23 | 2013-09-10 | Idenix Pharmaceuticals Inc | Procedimiento para preparar un producto intermedio sintético para la preparación de nucleósidos ramificados |
| WO2007127010A2 (en) | 2006-03-29 | 2007-11-08 | The Regents Of The University Of California | Diarylthiohydantoin compounds |
| EP2620432A3 (de) * | 2007-10-26 | 2013-12-18 | The Regents Of the University of California | Diarylhydantoinverbindungen |
| CN105722977A (zh) | 2013-10-30 | 2016-06-29 | 绿色生活生物技术有限责任公司 | 用于柑橘绿化枯萎病的发病定量系统和治疗方法 |
| CN103772460B (zh) * | 2014-02-14 | 2016-02-10 | 江苏省中国科学院植物研究所 | 蚕虫草中虫草素的提取工艺 |
| GB201718804D0 (en) * | 2017-11-14 | 2017-12-27 | Nuclera Nucleics Ltd | Novel use |
| US11279981B2 (en) | 2018-09-24 | 2022-03-22 | University Of South Florida | Biomarkers of low grade glioma and pediatric neuroblastoma |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE842642L (en) * | 1983-10-31 | 1985-04-30 | Harvard College | Purine Derivatives |
| US4724232A (en) * | 1985-03-16 | 1988-02-09 | Burroughs Wellcome Co. | Treatment of human viral infections |
| DE3627024A1 (de) * | 1985-09-24 | 1987-04-02 | Hoechst Ag | In 6- und 9-stellung substituierte 2-aminopurine, ihre verwendung, diese purine enthaltende arzneimittel und verfahren zur herstellung der purine |
| US5180824A (en) * | 1990-11-29 | 1993-01-19 | Berlex Biosciences Inc. | 6-azido-2-fluoropurine, useful in the synthesis of nucleosides |
| US5602246A (en) * | 1992-11-25 | 1997-02-11 | Schering Aktiengesellschaft | Process for the preparation of fludarabine or fludarabine phosphate from guanosine |
| US5457187A (en) * | 1993-12-08 | 1995-10-10 | Board Of Regents University Of Nebraska | Oligonucleotides containing 5-fluorouracil |
| AU709345B2 (en) * | 1995-09-07 | 1999-08-26 | Emory University | Therapeutic azide compounds |
-
1996
- 1996-09-06 AU AU71076/96A patent/AU709345B2/en not_active Expired
- 1996-09-06 WO PCT/US1996/014494 patent/WO1997009052A1/en not_active Ceased
- 1996-09-06 DE DE69638137T patent/DE69638137D1/de not_active Expired - Lifetime
- 1996-09-06 EP EP96932197A patent/EP0852499B1/de not_active Expired - Lifetime
- 1996-09-06 AT AT96932197T patent/ATE459361T1/de not_active IP Right Cessation
- 1996-09-06 JP JP9511450A patent/JPH11512397A/ja not_active Ceased
- 1996-09-06 CA CA002231442A patent/CA2231442A1/en not_active Abandoned
- 1996-09-06 BR BR9610120-2A patent/BR9610120A/pt not_active Application Discontinuation
-
1998
- 1998-03-03 US US09/033,996 patent/US6271212B1/en not_active Expired - Lifetime
-
2001
- 2001-05-04 US US09/849,870 patent/US6949521B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69638137D1 (de) | 2010-04-15 |
| US20010036930A1 (en) | 2001-11-01 |
| EP0852499A1 (de) | 1998-07-15 |
| WO1997009052A1 (en) | 1997-03-13 |
| US6271212B1 (en) | 2001-08-07 |
| CA2231442A1 (en) | 1997-03-13 |
| EP0852499B1 (de) | 2010-03-03 |
| EP0852499A4 (de) | 2001-03-07 |
| AU709345B2 (en) | 1999-08-26 |
| BR9610120A (pt) | 1999-12-21 |
| JPH11512397A (ja) | 1999-10-26 |
| AU7107696A (en) | 1997-03-27 |
| US6949521B2 (en) | 2005-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE459361T1 (de) | Therapeutische azidverbindungen | |
| HUP0100949A2 (hu) | Aril kondenzált azapoliciklusos vegyületek és ezeket tartalmazó gyógyászati készítmények | |
| HUP0001232A2 (hu) | Béta-amiloid peptid kibocsátást és/vagy szintézist gátló cikloalkil-, laktám-, laktonszármazékok, és ezek tio-analógjai, valamint e vegyületeket tartalmazó gyógyászati készítmények | |
| DK0590919T3 (da) | Terapeutiske midler mod Parkinsons sygdom | |
| HUP0102851A2 (hu) | Parazitaellenes artemizinin-származékok (endoperoxidok), eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények | |
| HUP0003309A2 (hu) | Imidazolilcsoportot tartalmazó gyűrűs acetálok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények | |
| AR012315A1 (es) | Derivados de ditiolan y el uso de los mismos en la fabricacion de un medicamento. | |
| LU90283I2 (fr) | Sporanox soluté buvable et ses dérivés pharmaceutiquement acceptables | |
| NL970006I1 (nl) | Gebruik van indolon-derivaten voor het bereiden van geneesmiddelen ter behandeling van de ziekte vanParkinson. | |
| ATE161836T1 (de) | 4-substituierte-2-deoxy-2,3-didehydro alpha-d- neuraminsäure antivirale derivate | |
| ATE202932T1 (de) | Stabilisierte arzneizusammensetzung enthaltend 10-hydroxy-7-ethylcamptothecin als lakton-verbindung | |
| DK1033981T3 (da) | Formuleringer og fremgangsmåder til nedsættelse af antineoplastiske midlers toksicitet | |
| HUP0300641A2 (hu) | Triazaspiro[5.5]undekán-származékok és hatóanyagként ezeket tartalmazó gyógyszerkészítmények | |
| ES2147836T3 (es) | Derivados de 4,5-diariloxazol. | |
| DE69111232D1 (de) | 5-benzyl barbitursäurederivate. | |
| YU13396A (sh) | N-(3-benzofuranil) urea derivati, postupci za njihovo dobijanje, kompozicije koje ih sadrže i njihova upotreba u lekovima | |
| FR2613365B1 (fr) | Nouveaux derives de l'amino tetrahydro-5, 6, 7, 8 naphto (2, 3b) furanne, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent | |
| MX9203417A (es) | Compuestos de diarilo antiateroescleroticos. | |
| HUP0103303A2 (hu) | Imidazolvegyületek, eljárás előállításukra, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
| ES8801281A1 (es) | Procedimiento para la obtencion de benzo-(pirano y tiopirano)-piridinas | |
| IL140468A0 (en) | Benzoxazole derivatives and pharmaceutical compositions containing the same | |
| ES2164869T3 (es) | Conjugados lipidos especificos de nucleosidos-difosfato y su uso como medicamentos. | |
| DK0541407T3 (da) | Nitrogenholdige, bicykliske derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende dem | |
| HUP0001773A2 (hu) | Szubsztituált tetrahidropiridinszármazékok, eljárás előállításukra, továbbá a vegyületeket tartalmazó gyógyászati készítmények | |
| EE05300B1 (et) | Akrloldistamtsiini derivaati sisaldav farmatseutiline kompositsioon, derivaadi kasutamine tuumorivastase ravimi valmistamiseks ning kombineeritud ravimpreparaat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |